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Abstract
Background: Despite widely acknowledged WHO guidelines for the integration of TB and HIV
services, heavily burdened countries have been slow to implement these and thus significant missed
opportunities have arisen.
Discussion:  The individual-centred, rights-based paradigm of the SA National AIDS Policy,
remains dissonant with the compelling public-health approach of TB control. The existence of
independent and disconnected TB and HIV services results in a wastage of scarce health resources,
an increased burden on patients' time and finances, and ignores evidence of patients' preference for
an integrated service. The current situation translates into a web of unacceptable, ongoing missed
opportunities such as failure to maximize collaborative disease surveillance, VCT, adherence
support, infection control, and positive prevention. TB services present a readily identifiable cohort
for HIV provider-initiated testing. Integrating HAART and DOTS will promote efficient usage of
health workers' time and a more navigable experience for patients, ultimately ensuring increased
TB treatment completion rates and MDR-TB prevention. As direct observation evolves into a
more supportive, empowering experience for patients, adherence to both TB drugs and HAART
will be bolstered. Little attention has been paid to the transmission of TB within HIV services. Low
cost infection control interventions include: triaging patients, scheduling new and follow-up patients
separately; well-ventilated, sheltered waiting rooms; and the use of personal respirators by patients
and staff. A more patient-centred approach to TB care may be able to recruit the active
participation of TB patients in positive prevention efforts, including maximizing personal infection
control, limiting exposure of social contacts to TB during the intensive phase of treatment,
advocating isoniazid prophylaxis within the home and patient-centred education efforts to reduce
overall transmission. Several model programmes demonstrated synergy, in which the impact of the
"whole" or integrated response was greater than the sum of the non-integrated parts.
Summary: The full potential of an integrated TB-HIV service has not been fully harvested. Missed
opportunities discount existing efforts in both programmes, will perpetuate the burden of disease,
and prevent major gains in future interventions. This paper outlines simple, readily-implementable
strategies to narrow the gap and reclaim existing missed opportunities.
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Background
The devastating interaction between the human immuno-
deficiency virus (HIV) and tuberculosis (TB) has become
increasingly reflected in the scientific literature. HIV has
resurrected TB as a global health concern, while TB has
amplified the mortality from HIV substantially[1]. Nega-
tive outcomes for co-infected individuals and discon-
nected, inadequate services which fail to optimally deal
with both epidemics are particularly evident in resource
limited settings[2]. In recognition of the deleterious inter-
action between these diseases, the World Health Organi-
sation(WHO) has developed guidelines for the
collaboration of both modalities of care in the pursuit of
a coherent, responsive and adequate model[3]. Despite
the growing evidence base and the WHO's resounding
calls for a stronger connection between TB and HIV care,
many of the hardest hit countries have been slow to
implement these recommendations on a wide scale[4].
The current situation translates into a web of unaccepta-
ble, ongoing missed opportunities such as failure to max-
imize HIV counselling and testing, collaborative disease
surveillance, adherence support, infection control, and
positive prevention (Table 1).
KwaZulu-Natal(KZN), home to nearly 10 million people,
is one of the poorest provinces in South Africa and is at the
epicentre of the HIV and TB pandemics. In 2006, the inci-
dence of TB in KZN was 1076/100000[5], the HIV preva-
lence was 39.1%[6] and 80% of TB patients were co-
infected with HIV[7]. HIV has resurrected the TB epidemic
over the past decade and threatens the already weak pro-
vincial health system, in which some facilities have a TB
directly observed therapy short-course(DOTS) coverage of
less than 30% and others have no TB DOTS programme at
all[8]. We share our experiences, from studying the HIV-
TB interaction in an urban TB clinic and a specialist TB
hospital, on pragmatic strategies for successfully integrat-
ing HIV and TB care in the public sector, and highlight sig-
nificant existing missed opportunities in TB/HIV. The
clinic is located in the central business district adjacent to
a transportation nodal point, and adjoining an HIV
research clinic and treatment programme. Each year
approximately 9000 new patients are diagnosed with TB
at the clinic; 91 percent of whom are black, 61% male and
53% unemployed. The specialist TB hospital is a public
sector specialist referral hospital for the management of
TB in KZN, within the South African district health sys-
tem. There are currently 160 beds, with the inpatient pop-
ulation almost exclusively(97%) comprising patients
infected with drug resistant tuberculosis.
Despite an HIV-TB co-infection rate of approximately
75% in some settings[9], the SA National TB Control Pro-
gramme (SANTCP) and HIV/AIDS control efforts remain
largely separate. The transformation of the TB landscape
by HIV, demands a public health response that extends
well beyond the traditional boundaries of TB control.
Similarly, HIV cannot be adequately managed if its inti-
mate relationship with TB is not reflected in HIV services.
The public health response to HIV has focused on individ-
uals and safely guarded their right to confidentiality. This
inclination toward the rights of the individual with mini-
mal focus on the competing rights of the community is
maintained throughout the spectrum of HIV care. The
response to TB has always been quite different with the
historical response including many restrictions to per-
sonal rights. Patients were "institutionalized" and sub-
jected to the necessary treatment in a seemingly
paternalistic manner. While much has changed in terms
of aligning the response to TB with human rights, the
response still reflects an interest in the competing rights of
the public, and the need to prevent spread of infection.
Programmes have been targeted at communities, and little
effort has been made to protect the individual. While TB
programmes have benefited from initiatives such as care
support buddies and tracing of defaulters, non-disclosure
in HIV presents a barrier to treatment adherence. Moreo-
ver, it is difficult to shape a public health policy for HIV
care with an HIV programme that is individual-centred.
The individual-centred, rights-based paradigm, which
characterizes much of the SA National AIDS Policy, there-
fore remains dissonant with the compelling public-health
approach of TB control.
The high HIV prevalence in TB patients make these
patients and health centres a readily identifiable cohort
and facility for efficiently providing HIV counselling, test-
ing and entry into the continuum of HIV care services.
Moreover, the high prevalence of HIV in TB suspects
strengthens the call for an integrated TB-HIV service[10].
The sustainable and pragmatic solution to the dual epi-
demics of HIV and TB in sub-Saharan Africa is not as sim-
ple as the expansion of either Highly Active Antiretroviral
Therapy(HAART) or the TB DOTS strategy independently.
The growing body of scientific literature remains ambiva-
lent on the impact of successful HAART programmes on
the burden of TB [11-13]. Factors which are believed to
limit this impact include: incomplete TB risk reduction
during HAART, late initiation of HAART, low community
HAART coverage, and increased life expectancy which
extends the period during which HAART patients may
Table 1: Key missed opportunities in TB/HIV
1. Counselling and testing
2. Surveillance
3. Adherence support
4. Infection control
5. Positive preventionBMC Public Health 2009, 9:243 http://www.biomedcentral.com/1471-2458/9/243
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develop TB [11,14]. The ambivalence surrounding the
impact of HAART programmes in South Africa on the bur-
den of TB may also allude to the importance of eliminat-
ing the disjointedness of existing TB and HIV services, in
order to maximise the role that HAART may play in reduc-
ing community risk of TB[11,12].
The existence of independent and mutually disconnected
TB and HIV care systems results in a wastage of scarce
health sector resources, an increased burden on patients'
time and finances, and ignores evidence of patients' pref-
erence to attend an integrated service[10,15]. More
importantly, the current situation translates into a web of
unacceptable, ongoing missed opportunities. Lessons
learned during the past 5 years of HAART scale-up could
be applied to the older and less robust TB system, increas-
ing efficiency and effectiveness while simultaneously inte-
grating responses. However, it must be noted that both
systems have much to learn from the other, and it is naïve
to believe that the TB system is the only beneficiary of a
more intimately connected TB-HIV service. TB pro-
grammes have decades of experience with standardised
treatment procedures, including recording and reporting,
which will be invaluable to a partnership with the HIV
programme[16,17]. Several model programmes demon-
strated synergy, in which the impact and quality of the
"whole" or integrated response was greater than the sum
of the non-integrated parts[18]. In contrast, non-integra-
tion results in less than optimal care for both patient
groups. While some have cited change within public
health systems as complicated and expectedly gradual,
Stephen Lewis former special envoy for HIV/AIDS in
Africa, has called the sluggish response "almost crimi-
nal"[19]. While we acknowledge that integrated services
are challenging to implement in our setting due to the
established vertical approach to TB and HIV care, huge
patient loads and significant staff shortages, it is crucial to
identify and minimise existing missed opportunities if we
are to change the trajectory of the dual epidemics.
Attempts to maximize TB interventions will be under-
mined without an assessment of the profile of patients
who present to TB facilities. The South African TB services
have largely been informed by the epidemiological his-
tory of the disease. Key gender and age assumptions sig-
nificantly impacted the design and delivery of the services.
Almost 70% of all TB patients at our TB facility are now
under the age of 45, and almost 40% of all patients are
female[20]. Even globally, women account for approxi-
mately 36% of smear-positive cases[21]. Despite the sub-
stantial evolution of the disease, particularly under the
influence of HIV in the developing world, health services
have failed to appreciate and respond to the changes, let
alone seize the new opportunities presented by the chang-
ing profile of patients. Challenging the underlying demo-
graphic assumptions which inform the design and
delivery of existing TB programmes, such as the belief that
TB is primarily a disease of men, will also be necessary if
we are to respond to the epidemic appropriately[1]. As TB
and HIV services become more intimately connected,
there will be an increasing demand for services to be
responsively designed for the patient population profile.
Discussion
Guiding Principles
Two fundamental principles should guide efforts to con-
struct an integrated complementary response. Firstly, the
opportunity presented by the continued scale-up of com-
prehensive HIV/AIDS care including HAART to simultane-
ously scale-up the integration of TB and HIV services
should be fully exploited. Secondly, scientific knowledge
and operational experience gained must diffuse freely
between the methodologically distinct TB and HIV serv-
ices. Scientific and practical knowledge generated since
the discovery of HIV 25 years ago should permeate into
existing approaches to TB. Conversely, expanding the
public health approach of TB control efforts to the
patient-centred, rights based approach of HIV/AIDS con-
trol is necessary if we are to maximise the impact of a syn-
ergised programme.
Areas of focus
Several points along the continuum of comprehensive
care present opportunities for applying the lessons
learned between HIV and TB services (Table 1):
With respect to HIV counselling and testing, TB services
present a readily identifiable cohort for HIV provider-ini-
tiated testing (PIT). Service integration in this cohort will
undoubtedly increase HIV screening for this high risk
cohort. Studies in other African countries have shown that
patients are willing to attend integrated services and that,
if provided, uptake of voluntary counselling and test-
ing(VCT) or PIT is high[15,22]. Given the 15% annual risk
of developing TB in HIV infected individuals[4], a more
intimate connection between TB and HIV services would
aid early diagnosis and management of TB. PIT in TB clin-
ics can focus on the clinical requirement to know a
patient's status in order to provide appropriate medical
care[23]. In addition to PIT, point of care CD4 count test-
ing can be conducted to minimise the delay between HIV
testing and enrolment into HIV care. The proportion of
notified TB patients who have a known HIV status at the
end of their outpatient TB treatment at our urban TB clinic
using conventional VCT was 21.7% in 2007, having
increased from 8.8% in 2004 (p < 0.0001) (Table 2).
Amongst patients admitted for treatment of multi-drug
resistant(MDR) TB, 51.5% of patients had a known HIV
status in 2003, having decreased from 65.7% in 2000 (p <
0.002) (Table 3). It is likely that these patients would haveBMC Public Health 2009, 9:243 http://www.biomedcentral.com/1471-2458/9/243
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had multiple encounters with health care providers before
and during admission, yet the proportion of patients with
a known HIV status remains unacceptably low. With the
expansion of outpatient VCT facilities in many hospitals
and an emphasis on privacy and confidentiality, the wards
may increasingly be viewed as unsuitable for VCT. In addi-
tion, dually infected inpatients may be perceived to be too
ill for VCT or unprepared to deal with a second diagnosis.
Given the ambivalence regarding the timing of HAART
initiation in TB patients, clinicians may not see the
urgency in establishing an HIV diagnosis in an ill TB
patient. While randomized studies examining the timing
of HAART initiation in TB patients are still underway, pre-
liminary data from our centre suggests a reduction in mor-
tality in excess of 50% if TB treatment and HAART are
integrated[24]. The downward trend in the proportion of
inpatients that have a known HIV status is concerning,
and illustrates a sizable missed opportunity in this setting.
A patient-centred approach to VCT in HIV services has
evolved successfully. The perceived lack of respect for con-
fidentiality at TB facilities may have rendered it unattrac-
tive and unsafe as site for HIV counselling and testing[22].
Combating the stigma associated with HIV, whilst simul-
taneously preserving respect for confidentiality by ensur-
ing privacy in the setting and communication is essential.
To enhance the uptake of counselling and testing, patients
in the various waiting areas in our TB clinic receive simple
key messages from health care workers on TB and HIV.
Initially this intervention was directed at large groups of
patients but has evolved into smaller group discussions of
4–6 individuals to improve exchange of information
between patients and health care workers. Efficient use of
patients' time in the TB waiting area is maximized at our
centre by delivering health care messages to a captive
audience without interfering with the procedures con-
ducted and flow of patients at the clinic. A similar com-
mitment to patient education has not, however, diffused
into the HIV care setting. Rarely, if ever, are formal patient
education programmes focused on TB presented to this
high risk group. Such programmes may assist the health
system in early identification of TB cases by promoting
self-reporting by patients.
The WHO and UNAIDS have identified TB facilities in set-
tings of high HIV prevalence as important sites for addi-
tional HIV surveillance. Integrated TB-HIV services will
contribute to our knowledge of both epidemics, and facil-
itate the estimation of the burden of coinfection. As coin-
fected patients are symptomatic from HIV infection,
surveillance at integrated clinics will provide a good esti-
mate of the burden of HIV disease and mortality. This is
substantially different from HIV surveillance at antenatal
clinics where patients are generally asymptomatic from
HIV infection, and only an estimation of population level
infection is obtained. Estimates of HIV disease burden in
coinfected patients will provide crucial direction to
resource allocation and future health care planning. The
active monitoring of patients in HIV clinics for the devel-
opment of TB is an essential element of closer linkages
between TB and HIV centres. Routine symptom check lists
and clinical cues may be employed at HIV clinics to
increase vigilance and identification of TB cases. This will
Table 2: HIV status of patients on TB treatment at a TB referral facility in Durban, South Africa
Year No. of patients seen No. of patients with known HIV status(%)
2004 8716 770 (8.8%)
2005 8567 1145 (13.4%)
2006 8180 1392 (17.0%)
2007 7202 1564 (21.7%)
P < 0.0001 (Chi-square for trend)
Table 3: HIV status of patients on treatment for Multi-Drug Resistant Tuberculosis(MDR-TB) at an MDR referral facility in Durban, 
South Africa
Year No. of patients admitted No. of patients with known HIV status(%)
2000 204 134 (65.7%)
2001 266 159 (59.8%)
2002 384 228 (59.4%)
2003 435 224 (51.5%)
P < 0.002 (Chi-square for trend)BMC Public Health 2009, 9:243 http://www.biomedcentral.com/1471-2458/9/243
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serve as a method of TB case finding in high risk group, as
well as give expression to the intimate relationship
between TB and HIV to clinicians and patients.
Adherence support presents opportunities for enhancing
patient support and improving resource utilization. Inte-
grating HAART and the TB DOTS strategy in a manner
suitable to the local conditions will initially require
investment in health worker training and service reorgan-
ization. However, long-term benefits will include efficient
usage of health workers' time and a more easily navigable
experience for patients, ultimately ensuring increased TB
treatment completion rates and MDR-TB prevention.
DOT for TB originated almost half a century ago as a
method of ensuring adherence to TB drugs and comple-
tion of treatment, and is the most successful and well
studied of adherence interventions[25]. DOTS pro-
grammes for TB could provide the necessary infrastructure
through which DOT for HAART could be conducted. As
direct observation evolves into a more supportive,
empowering experience for patients, adherence to both
TB drugs and HAART will be bolstered. This Modified
Directly Observed Therapy(in which not all medication
doses are administered under direct observation) may
also present an opportunity for more closely monitoring
adherence to HAART. A pilot study at our TB clinic
revealed that a modified DOTS approach, in which the
administration of TB medication and HAART was directly
observed on weekdays and self-administered on week-
ends, resulted in a well-tolerated, acceptable and thera-
peutically beneficial treatment programme[25]. Such a
programme may provide an initial structured and super-
vised HAART experience from which transition may be
made toward greater self-administration. Currently at the
adjoining HIV clinic, patients self-administer their HAART
and receive adherence counselling at five strategic points
in their care. These sessions are used to familiarize
patients with their diagnosis, the drug therapy they will be
exposed to, relevant time-frames, the importance of
adherence, and the consequences of non-adherence.
These interactions with patients focus on empowering
patients and promoting autonomy and commitment to
treatment, while emphasising the benefits of adherence.
These patients are also counselled on the risk of acquiring
TB as well as the symptoms they should be vigilant for. At
the TB clinic, patients receive minimal counselling, and
few are familiar with their treatment plan or the conse-
quences of non-adherence. In a health systems assessment
of KwaZulu Natal, it was found that merely 29% of TB
patients knew that their full course of treatments should
be completed, and only 2% knew that TB had to be treated
for a minimum of 6 months[8]. These lessons from ART
should be integrated into TB services to improve under-
standing of and adherence to treatment, stem the high TB
treatment interruption rates and sufficiently educate
patients in protecting themselves from re-infection and
infecting others. An often neglected element in improving
adherence is the commitment and attitude of health care
workers who may not necessarily be a part of the formal
adherence support programme. A supportive, sensitive,
respectful and encouraging attitude from all healthcare
workers may promote adherence by making clinic visits
more pleasant[8]. The growing call for increased commu-
nity participation and patient-support as part of the STOP
TB Strategy, can be gainfully directed to a less imposing
and more empowering treatment programme[4]. This
approach will be more respecting of patients' rights to dig-
nity and choice, as set out in the The Patients' Charter for
Tuberculosis Care[4]. A single strategy for bolstering
adherence to both TB and ARV therapies makes more pro-
grammatic sense, and will be more logical and practical to
patients, who, unlike the healthcare system, do not com-
partmentalize their illnesses. A less fragmented approach
will advance the paradigm of 'treating the patient and not
just the disease'.
Until recently, little attention has been paid to TB infec-
tion control measures in the developing world. The grow-
ing evidence of nosocomial transmission of the infection
in both inpatient and outpatient settings has failed to
arouse a compelling attempt to address the issue[26,27].
In the era of the dual epidemics of TB and HIV, even less
attention has been paid to the transmission of TB within
HIV facilities. The risk of TB transmission to health care
workers and other HIV infected patients is an understand-
able challenge to HIV services which articulate intimately
with TB services[26]. As a result of the increased risk of
negative acid-fast bacilli sputum-smear results in TB-HIV
coinfected individuals, there is often a delay in the diag-
nosis of TB, with a consequently increased exposure to
other HIV service users and health care workers[28]. The
contribution of smear negative TB to ongoing transmis-
sion may have been underestimated, particularly in terms
of transmission to immuno-compromised contacts[28].
TB infection control measures in HIV services is based on
a three level hierarchy of controls, including administra-
tive or workplace controls, environmental controls, and
personal respiratory protection[2]. Low cost interventions
include proper and innovative triaging of patients, with
expeditious attention to coughing patients. Preventing re-
infection of patients in the continuation phase of treat-
ment may include scheduling new and follow-up patients
on separate days. Open, well-ventilated, sheltered waiting
rooms may be a simple alternative to more sophisticated,
resource requiring infrastructure. Without making struc-
tural changes to our TB clinic, large waiting areas have
been redesigned in favour of multiple smaller waiting
areas with open air cover. In addition, a separate well ven-
tilated area is used for known cases of drug resistant TB.
Existing structures in established primary health care clin-BMC Public Health 2009, 9:243 http://www.biomedcentral.com/1471-2458/9/243
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ics, at which the majority of TB patients receive care, can
be economically modified to improve infection control.
In a model of nosocomial transmission of extensively
drug-resistant TB in this setting, it was found that
improvements to natural ventilation could prevent 33%
(8–35%, 95% CI) of future XDR-TB cases[27]. Personal
respiratory protection is usually uncomfortable and when
made available is ineffectively used in most health set-
tings[29]. Nonetheless, all patients are requested to use
surgical masks, while health care workers are provided
with personal respirators. However, there is currently no
assessment of air quality changes, and staff often com-
plain of a poor face seal of the masks as well as the dis-
comfort of using the mask during the high temperatures
experienced in this part of the world. While TB among
health care workers constitutes a relatively small propor-
tion of all TB cases, the criticality of staff availability and
occupational safety warrants our attention. Promoting
HIV testing among health care workers, redeploying HIV
infected workers away from the TB unit and ensuring strict
adherence to mask use may prevent more than two thirds
of staff XDR-TB infections, and possibly offer similar ben-
efits in drug sensitive TB[27]. In addition, early diagnosis
and treatment of TB as would be possible in an integrated
service would in itself represent a public health infection
control effort. Isoniazid prophylaxis remains an underuti-
lized measure to reduce TB transmission in HIV services,
especially among patients with a past history of TB[2,30].
Finally, HIV has propelled the innovative approach of
positive prevention for intervening in both the transmis-
sion of infection and the development of illness. The
strong prevention arm of HIV programmes is only vaguely
present in the TB programme, and is usually confined to
isoniazid prophylaxis for contacts of TB patients. Key les-
sons and opportunities for positive prevention in TB have
not been fully exploited. A more patient-centred approach
to TB care may be able to recruit the active participation of
TB patients in positive prevention efforts, which could
include maximizing personal infection control, limiting
exposure of social contacts to TB during the intensive
phase of treatment, advocating isoniazid prophylaxis
within the home and patient-centred education efforts to
reduce overall transmission. Disclosure of HIV status
remains a significant challenge to HIV prevention. While
a pilot study at our clinic revealed that approximately two
thirds of patients disclosed their status to one other per-
son with the hope of receiving support from them, only
few patients disclosed it to their sexual partner[31]. The
common law of South Africa places an ethical and moral
duty on the health system to inform vulnerable unin-
fected partners of TB and HIV infected patients, after
impressing upon the patient the importance of disclosure
to their sexual partners. Importantly, these partners have
a reciprocal moral and ethical duty to receive such infor-
mation. Partner notification for HIV may subtly and
opportunistically piggy-back on contact tracing efforts in
TB. Even without this, contacts of TB who present to
health services in response to TB contact tracing can be
considered a high-risk, readily identifiable cohort for HIV
testing. Every patient, therefore, serves as an entry point to
a network of vulnerable individuals[17]. The assessment
of vulnerability in our context is a complex issue and
undoubtedly requires a thorough evaluation of the pros
and cons of facilitating such a disclosure to sexual partners
of the patient.
Summary
The deleterious interaction between the dual epidemics of
TB and HIV has crippled the health systems of many
developing countries. While significant gains have been
made in the last decade, including the roll-out of HAART
and the implementation of the DOTS Strategy, many les-
sons are yet to be learned. Perhaps, the greatest conse-
quences will arise, not from what has been done, but
rather from what has been failed to be done. Indeed, TB
and HIV have presented many challenges independently
and through their interaction, but their close association
has also created fertile ground for cross-pollination of
knowledge and ideas between the historically distinct sci-
entific communities and health programmes. The result is
a wasteful failure to seize the opportunities presented by
the intimate intertwining of the TB and HIV epidemics.
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